Literature DB >> 33515983

Recent advances in point-of-care diagnostics for oral cancer.

Jasmeen Kaur1, Rohit Srivastava1, Vivek Borse2.   

Abstract

Early-stage diagnosis is a crucial step in reducing the mortality rate in oral cancer cases. Point-of-care (POC) devices for oral cancer diagnosis hold great future potential in improving the survival rates as well as the quality of life of oral cancer patients. The conventional oral examination followed by needle biopsy and histopathological analysis have limited diagnostic accuracy. Besides, it involves patient discomfort and is not feasible in resource-limited settings. POC detection of biomarkers and diagnostic adjuncts has emerged as non- or minimally invasive tools for the diagnosis of oral cancer at an early stage. Various biosensors have been developed for the rapid detection of oral cancer biomarkers at the point-of-care. Several optical imaging methods have also been employed as adjuncts to detect alterations in oral tissue indicative of malignancy. This review summarizes the different POC platforms developed for the detection of oral cancer biomarkers, along with various POC imaging and cytological adjuncts that aid in oral cancer diagnosis, especially in low resource settings. Various immunosensors and nucleic acid biosensors developed to detect oral cancer biomarkers are summarized with examples. The different imaging methods used to detect oral tissue malignancy are also discussed herein. Additionally, the currently available commercial devices used as adjuncts in the POC detection of oral cancer are emphasized along with their characteristics. Finally, we discuss the limitations and challenges that persist in translating the developed POC techniques in the clinical settings for oral cancer diagnosis, along with future perspectives.
Copyright © 2021 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Biomarkers; Diagnostic adjuncts; Oral cancer; Point-of-care

Mesh:

Year:  2021        PMID: 33515983     DOI: 10.1016/j.bios.2021.112995

Source DB:  PubMed          Journal:  Biosens Bioelectron        ISSN: 0956-5663            Impact factor:   10.618


  4 in total

1.  Arecoline Is Associated With Inhibition of Cuproptosis and Proliferation of Cancer-Associated Fibroblasts in Oral Squamous Cell Carcinoma: A Potential Mechanism for Tumor Metastasis.

Authors:  Jinfei Li; Shuangyi Chen; Yuxuan Liao; Hongyi Wang; Dawei Zhou; Bo Zhang
Journal:  Front Oncol       Date:  2022-07-07       Impact factor: 5.738

Review 2.  Recent Developments in the Field of Optical Immunosensors Focusing on a Label-Free, White Light Reflectance Spectroscopy-Based Immunosensing Platform.

Authors:  Chrysoula-Evangelia Karachaliou; Georgios Koukouvinos; Dimitrios Goustouridis; Ioannis Raptis; Sotirios Kakabakos; Evangelia Livaniou; Panagiota Petrou
Journal:  Sensors (Basel)       Date:  2022-07-07       Impact factor: 3.847

3.  Diagnostic accuracy of Raman spectroscopy in oral squamous cell carcinoma.

Authors:  Ruiying Han; Nan Lin; Juan Huang; Xuelei Ma
Journal:  Front Oncol       Date:  2022-08-05       Impact factor: 5.738

4.  Identification of Potential miRNA-mRNA Regulatory Network in the Development of Oral Cancer.

Authors:  Yun Yang; Xin Xin; Ting Xu
Journal:  Dis Markers       Date:  2022-08-18       Impact factor: 3.464

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.